Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.47B
Total Bought:
$318.96M
Total Sold:
$225.41M
Net Transaction:
+$93.55M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V4,360,0003,200,000-1,160,000$196.33M$189.34M12.92%-$6.99M
Nuvalent Inc1,487,7561,487,7560$111.72M$112.86M7.70%+$1.15M
Xenon Pharmaceuticals Inc.(XENE)2,167,7932,754,266+586,473$93.32M$107.39M7.33%+$14.07M
Vaxcyte, Inc.(PCVX)860,0001,305,000+445,000$58.75M$98.54M6.73%+$39.79M
Enliven Therapeutics Inc3,973,2453,973,2450$69.89M$92.85M6.34%+$22.97M
Vera Therapeutics, Inc.CL A(VERA)3,165,0002,475,000-690,000$136.47M$89.55M6.11%-$46.93M
Cogent Biosciences, Inc.(COGT)6,425,0009,738,000+3,313,000$43.18M$82.09M5.60%+$38.92M
Soleno Therapeutics Inc169,5331,425,000+1,255,467$7.26M$58.14M3.97%+$50.88M
Celldex Therapeutics, Inc.(CLDX)866,4681,425,000+558,532$36.37M$52.74M3.60%+$16.37M
Mind Medicine Mindmed Inc5,833,3337,145,888+1,312,555$54.83M$51.52M3.52%-$3.31M
Rhythm Pharmaceuticals, Inc.(RYTM)1,050,0001,225,000+175,000$45.50M$50.30M3.43%+$4.80M
Arvinas, Inc.(ARVN)1,275,0001,884,361+609,361$52.63M$50.16M3.42%-$2.47M
Spyre Therapeutics, Inc.(SYRE)1,884,0841,988,084+104,000$71.46M$46.74M3.19%-$24.72M
Perspective Therapeutics, Inc.(CATX)04,657,345+4,657,345$0$46.43M3.17%+$46.43M
Pharvaris N V
COM
1,725,0001,810,175+85,175$39.86M$34.03M2.32%-$5.83M
Alkermes plcSHS(ALKS)01,375,000+1,375,000$0$33.14M2.26%+$33.14M
Viridian Therapeutics, Inc.(VRDN)1,934,6532,528,032+593,379$33.88M$32.89M2.25%-$986.1K
Kura Oncology, Inc.(KURA)1,525,0001,593,350+68,350$32.53M$32.81M2.24%+$278.8K
Nkarta, Inc.(NKTX)3,165,0004,151,034+986,034$34.21M$24.53M1.67%-$9.68M
Celcuity Inc.(CELC)1,555,9541,464,105-91,849$33.61M$23.98M1.64%-$9.63M
Third Harmonic Bio Inc1,250,0001,545,426+295,426$11.80M$20.09M1.37%+$8.29M
Immunovant, Inc.(IMVT)750,990750,9900$24.26M$19.83M1.35%-$4.44M
ABIVAX Société AnonymeADS(ABVX)1,895,0031,284,110-610,893$27.10M$16.98M1.16%-$10.12M
Syndax Pharmaceuticals, Inc.(SNDX)318,851825,000+506,149$7.59M$16.94M1.16%+$9.35M
C4 Therapeutics, Inc.(CCCC)3,410,3843,410,3840$27.86M$15.76M1.08%-$12.11M
ORIC Pharmaceuticals, Inc.(ORIC)2,000,0002,000,0000$27.50M$14.14M0.97%-$13.36M
Apogee Therapeutics Inc290,000290,0000$19.27M$11.41M0.78%-$7.86M
Cabaletta Bio, Inc.(CABA)1,100,0001,100,0000$18.77M$8.23M0.56%-$10.54M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
0750,000+750,000$0$7.54M0.52%+$7.54M
Neurogene Inc.(NGNE)200,000200,0000$10.18M$7.28M0.50%-$2.90M
Vistagen Therapeutics, Inc.(VTGN)1,575,0001,575,0000$8.32M$5.48M0.37%-$2.83M
Helix Acquisition Corp IiCL A500,000500,0000$5.20M$5.11M0.35%-$90.0K
Autolus Therapeutics plcADS(AUTL)2,300,0001,178,723-1,121,277$14.67M$4.10M0.28%-$10.57M
Arca Biopharma Inc0414,325+414,325$0$1.59M0.11%+$1.59M
Avalo Therapeutics, Inc.(AVTX)040,000+40,000$0$498.8K0.03%+$498.8K
Adicet Bio Inc1,374,3200-1,374,320$3.23M$0—-$3.23M
Adverum Biotechnologies Inc657,3330-657,333$9.29M$0—-$9.29M
Alpine Immune Sciences Inc1,375,0000-1,375,000$54.51M$0—-$54.51M
Dbv Technologies S AADR92,6870-92,687$69.4K$0—-$69.4K
Engene Holdings Inc
COM
1,250,0000-1,250,000$21.19M$0—-$21.19M
Kyverna Therapeutics, Inc.(KYTX)912,1890-912,189$22.66M$0—-$22.66M
MacroGenics, Inc.(MGNX)295,0200-295,020$4.34M$0—-$4.34M
Perspective Therapeutics, Inc.(CATX)21,052,6310-21,052,631$25.05M$0—-$25.05M
SAB Biotherapeutics, Inc.(SABS)183,1740-183,174$831.6K$0—-$831.6K
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q2 2024 | TickerTrail